Dr. Daniel Adam Brenner, MD, PhD

Dr. Brenner practices at Santa Rosa Surgery and Endoscopy Center in Santa Rosa, California.

Dr. Brenner's NPI, 1750561973, was assigned on November 5, 2007. Dr. Brenner graduated from Boston University School Of Medicine in 2007. Dr. Brenner holds California license A105376.

Dr. Brenner's primary practice is Santa Rosa Surgery and Endoscopy Center, at 34 Mark West Springs Road, Suite 100, Santa Rosa, CA 95403. The practice phone is (707) 541-3500.

Dr. Brenner's primary practice is Santa Rosa Surgery and Endoscopy Center in Santa Rosa, California. Dr. Brenner is also affiliated with Sutter Santa Rosa Regional Hospital. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Brenner to 4 more hospitals, 1 group practice or clinic, 1 rural health clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brenner practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Brenner's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Brenner is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Brenner's licenses on file in 2 states: California and Hawaii.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis, pacemaker or defibrillator implantation and pacemaker replacement among the conditions Dr. Brenner treats.

CMS data shows 4,858 Medicare services from Dr. Brenner across 42 procedure codes in 2024, for 1,505 Medicare patients. Medicare paid $307,135 for them.

CMS counts 1,505 Medicare patients who saw Dr. Brenner in 2024. The largest group is 75 to 84, with 611 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brenner's median patient age at 74, with 42% women.

In 2024, Dr. Brenner wrote 7,375 Medicare Part D claims for 1,006 patients. 73% of them were for generic drugs. CMS names the drug for 7,164 of them, across 56 drugs with 11 or more claims each, at $2,127,377 in total drug cost. In 2023, CMS named 6,034 claims across 51 drugs.

Dr. Brenner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brenner as offering telehealth. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. Brenner, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Brenner, published from 2004 to 2017. The most frequent topics are Aortic Valve Stenosis, Liver Cirrhosis and Non-alcoholic Fatty Liver Disease. Dr. Brenner has published most often in Aliment Pharmacol Ther. Dr. Brenner's most frequent co-authors are Juyong Brian Kim, MD, Alan Ching-Yuen Yeung, MD and David Allen Brenner, MD.

CMS Open Payments shows 386 general payments to Dr. Brenner from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Medtronic, Inc. paid the most, $8,087.

Dr. Brenner graduated from Boston University School Of Medicine in 2007. Dr. Brenner is a member of ACC.

Dr. Brenner is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.